Lupus Science & Medicine®
is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.
Impact factor: 3.9
Citescore: 5.0
All metrics >>
Publish in LSM
Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.
Information is also provided on editorial policies and open access.
This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.
All manuscripts should be submitted online.
Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.
Latest Articles
Letter:
Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report18 March 2024
Immunology and inflammation:
Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice12 March 2024
Immunology and inflammation:
Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis12 March 2024
Genetics:
Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations9 March 2024
Clinical trials and drug discovery:
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease7 March 2024
EURO LUPUS 2024
Lupus Science & Medicine is delighted to be the official journal of the 14th European LUPUS Meeting taking place in Bruges, Belgium 19-22 March 2024.
The meeting intends to share the latest clinical and basic advances in the field of systemic lupus erythematosus with concurrent sessions combining invited talks, oral and abstract presentations, a great debate and fishbowl sessions.
The abstracts from the conference will be published online as a supplement to Lupus Science & Medicine.
LSM Podcasts
Most Read Articles
Clinical trials and drug discovery:
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-1327 February 2024
Lupus nephritis:
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial22 August 2023
Clinical trials and drug discovery:
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies10 January 2024
Featured Video
Lupus Science & Medicine
The official journal of the Lupus Foundation of America and the premier open-access journal dedicated to lupus research.
Find out more